Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Polaryx Therapeutics, Inc. (PLYX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Polaryx Therapeutics, Inc. (PLYX), most recent 12 months reported: net loss $8.98M. Latest balance sheet on file: liquid cash $11.54M. From SEC filings. Others in Pharmaceutical Preparations: PEPGEN INC. · Phio Pharmaceuticals Corp. · PROTOKINETIX, INCORPORATED · PLIANT THERAPEUTICS, INC. · PROMIS NEUROSCIENCES INC. · PMV PHARMACEUTICALS, INC. · PROPANC BIOPHARMA, INC. · PRAXIS PRECISION MEDICINES, INC.

Stock screener

Watchlist